GR3020133T3 - Optically pure r(-) albuterol for treating asthma - Google Patents

Optically pure r(-) albuterol for treating asthma

Info

Publication number: GR3020133T3
Authority: GR; Greece
Prior art keywords: albuterol; optically pure; treating asthma; isomer; asthma
Prior art date: 1990-01-05

Application number

GR960401513T

Other languages

Greek (el)

English (en)

Inventor

Timothy J Barberich

James W Young

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-01-05

Filing date

1996-05-31

Publication date

1996-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23831837&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3020133(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-05-31 Application filed by Sepracor Inc filed Critical Sepracor Inc

1996-08-31 Publication of GR3020133T3 publication Critical patent/GR3020133T3/el

Links

208000006673 asthma Diseases 0.000 title abstract 3
NDAUXUAQIAJITI-LBPRGKRZSA-N (R)-salbutamol Chemical compound CC(C)(C)NC[C@H](O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-LBPRGKRZSA-N 0.000 title 1
NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 abstract 3
229960002052 salbutamol Drugs 0.000 abstract 3
229940124630 bronchodilator Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GR960401513T 1990-01-05 1996-05-31 Optically pure r(-) albuterol for treating asthma GR3020133T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46126290A	1990-01-05	1990-01-05
PCT/US1991/000088 WO1991009596A1 (en)	1990-01-05	1991-01-04	Optically pure r(-) albuterol for treating asthma

Publications (1)

Publication Number	Publication Date
GR3020133T3 true GR3020133T3 (en)	1996-08-31

Family

ID=23831837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR960401513T GR3020133T3 (en)	1990-01-05	1996-05-31	Optically pure r(-) albuterol for treating asthma

Country Status (11)

Country	Link
US (1)	US6083993A (de)
EP (1)	EP0509036B1 (de)
JP (1)	JP3085705B2 (de)
AT (1)	ATE135908T1 (de)
AU (1)	AU7174191A (de)
CA (1)	CA2073181C (de)
DE (1)	DE69118359T2 (de)
DK (1)	DK0509036T3 (de)
ES (1)	ES2085468T3 (de)
GR (1)	GR3020133T3 (de)
WO (1)	WO1991009596A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2289842B (en) *	1991-04-05	1996-01-31	Sepracor Inc	Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) *	1991-04-05	1991-05-22	Sandoz Ag	Improvements in or relating to organic compounds
CA2286913C (en) *	1997-04-30	2008-12-09	Bridge Pharma, Inc.	Composition and methods using an eutomer
WO1999042460A1 (en) *	1998-02-20	1999-08-26	Fine Chemicals Corporation (Proprietary) Limited	Process for the production of optically enriched (r)- or (s)-albuterol
ZA994264B (en)	1998-07-01	2000-01-25	Warner Lambert Co	Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en)	1999-06-29	2007-06-19	Mcneil-Ppc, Inc.	Stereoisomers with high affinity for adrenergic receptors
JP2003221335A (ja)	2001-10-26	2003-08-05	Dey Lp	慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030203930A1 (en) *	2001-10-26	2003-10-30	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en)	2001-10-26	2004-03-09	Dey, L.P.	Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) *	2001-10-26	2003-10-09	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030140920A1 (en) *	2001-10-26	2003-07-31	Dey L.P.	Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
AU2003226603A1 (en) *	2002-04-19	2003-11-03	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
EP1562975A2 (de) *	2002-10-25	2005-08-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten
US20050020692A1 (en) *	2003-07-24	2005-01-27	Ciofalo Vincent B.	Treatment of heaves
NZ547178A (en) *	2003-11-20	2008-06-30	Alteragon Pty Ltd	Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol
CA2570386A1 (en) *	2004-06-14	2005-12-29	Sepracor Inc.	Methods of using albuterol and calcium activated potassium channel openers
WO2005123072A1 (en) *	2004-06-14	2005-12-29	Sepracor Inc.	Methods and compositions for the treatment of pulmonary diseases
GB0501956D0 (en) *	2005-01-31	2005-03-09	Arrow Internat	Nebulizer formulation
WO2012087094A1 (es) *	2010-12-21	2012-06-28	Techsphere S.A. De C.V.	Composición farmacéutica inhalable para el tratamiento del asma por administración vía aérea mediante un succionador de emulación de aerosol
US9784726B2 (en)	2013-01-08	2017-10-10	Atrogi Ab	Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714736D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714745D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714740D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714734D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201903832D0 (en)	2019-03-20	2019-05-01	Atrogi Ab	New compounds and methods
GB202205895D0 (en)	2022-04-22	2022-06-08	Atrogi Ab	New medical uses
EP4651867A1 (de)	2023-01-20	2025-11-26	Atrogi AB	Beta 2-adrenergische rezeptoragonisten zur behandlung oder prävention von muskelschwund
GB202302225D0 (en)	2023-02-16	2023-04-05	Atrogi Ab	New medical uses
GB202303229D0 (en)	2023-03-06	2023-04-19	Atrogi Ab	New medical uses
GB202403169D0 (en)	2024-03-05	2024-04-17	Atrogi Ab	New medical uses
WO2025238248A1 (en)	2024-05-17	2025-11-20	Atrogi Ab	USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1298494A (en) *	1970-06-17	1972-12-06	Allen & Hanburys Ltd	Phenylethanolamine derivatives
US4965065A (en) *	1986-04-29	1990-10-23	Bristol-Myers Squibb Company	Gastroprotective process and compositions
EP0320550A1 (de) *	1987-12-18	1989-06-21	Bristol-Myers Company	NSAID-Zusammensetzungen mit Gehalt an H1-Blockern, H2-Blockern, beta-adrenergischen Agonisten oder Mischungen hiervon und an einem Alkalinisierungsmittel
GB9107196D0 (en) *	1991-04-05	1991-05-22	Sandoz Ag	Improvements in or relating to organic compounds

1991
- 1991-01-04 JP JP03502985A patent/JP3085705B2/ja not_active Expired - Lifetime
- 1991-01-04 AT AT91902520T patent/ATE135908T1/de not_active IP Right Cessation
- 1991-01-04 CA CA002073181A patent/CA2073181C/en not_active Expired - Lifetime
- 1991-01-04 AU AU71741/91A patent/AU7174191A/en not_active Abandoned
- 1991-01-04 ES ES91902520T patent/ES2085468T3/es not_active Expired - Lifetime
- 1991-01-04 EP EP91902520A patent/EP0509036B1/de not_active Expired - Lifetime
- 1991-01-04 DK DK91902520.5T patent/DK0509036T3/da active
- 1991-01-04 WO PCT/US1991/000088 patent/WO1991009596A1/en not_active Ceased
- 1991-01-04 DE DE69118359T patent/DE69118359T2/de not_active Expired - Lifetime
1996
- 1996-05-31 GR GR960401513T patent/GR3020133T3/el unknown
1999
- 1999-12-17 US US09/466,107 patent/US6083993A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP3085705B2 (ja)	2000-09-11
EP0509036A1 (de)	1992-10-21
WO1991009596A1 (en)	1991-07-11
DE69118359D1 (de)	1996-05-02
ATE135908T1 (de)	1996-04-15
AU7174191A (en)	1991-07-24
DK0509036T3 (da)	1996-07-29
CA2073181C (en)	2002-04-23
EP0509036B1 (de)	1996-03-27
DE69118359T2 (de)	1996-08-14
US6083993A (en)	2000-07-04
ES2085468T3 (es)	1996-06-01
JPH05503102A (ja)	1993-05-27
CA2073181A1 (en)	1991-07-06

Publication	Publication Date	Title
GR3020133T3 (en)	1996-08-31	Optically pure r(-) albuterol for treating asthma
DE68908722D1 (de)	1993-10-07	Dampf-Phasen-Verfahren zur Herstellung eines Diamanten.
FI922434A0 (fi)	1992-05-27	Produktion av rekombinant human interleukin-1-inhibitor.
CH664665GA3 (de)	1988-03-31
EP0656333A4 (de)	1996-08-21	Reagenz und verfahren zur trennung optischer isomere.
DE69202307D1 (de)	1995-06-08	Kryogenisches Rektifikationsverfahren zur Herstellung von gereinigtem Argon.
AU1315795A (en)	1995-07-17	Process for the preparation of an optically pure enantiomer of formoterol
IL75133A (en)	1988-12-30	Process for the preparation of 1,2-diacyl-s,n-glycerophosphocholines(or glycerophosphoethanolamines)and some novel intermediates therefor
PT724600E (pt)	2002-07-31	Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido
CA2061665A1 (en)	1992-08-26	Treatment of lower urinary tract disorders
CA2068128A1 (en)	1992-11-09	Process for the removal of olefinic impurities from 1,1,1,2,3,3,3-heptafluoropropane
BG104240A (en)	2001-04-30	Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
AU8634291A (en)	1992-10-06	Process and device for the manufacture of high-pressure laminates
PL313322A1 (en)	1996-06-24	Method of obtaining 9-(2-hydroxy)etyhoxymethylquanine
EP0970962A3 (de)	2001-04-11	Verfahren zur Herstellung von 2,2-Difluorketen-Silyl, 0,S-Acetale und alpha,alpha-Difluor-beta-Silyloxy-1, 3-Dioxolan-4-propansaure 0, S-estern
DE68909985D1 (de)	1993-11-25	Oberflächenschleifverfahren für ebene Bauteile.
AU1650292A (en)	1992-12-30	Process for obtaining dimethyl amine or trimethyl amine dehydrogenases, dehydrogenases obtained thereby and their use
WO1989005644A3 (en)	1989-11-16	Thienotricyclene for the treatment of bronchial diseases
ES8404693A1 (es)	1984-05-01	Procedimiento de preparacion de nuevos amino-14 esteroides.
AU3385689A (en)	1989-11-02	Bonding diamond to diamond
EP0474250A3 (en)	1993-04-07	Enzymatic process for separating the optical isomers of racemic 1,2-diols
AU2881089A (en)	1989-07-27	Abrasive and/or scouring pad, substitute for steel wool, and process for producing same
ZA815094B (en)	1982-08-25	Novel peptide
AU8314391A (en)	1992-03-17	Process for treatment of waste waters or equivalent impure waters as well as a flocculating adjuvant used in the process
AU4288796A (en)	1996-06-26	Novel processes for preparing ranitidine